HC Wainwright Raises Earnings Estimates for Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Equities research analysts at HC Wainwright upped their Q4 2025 EPS estimates for shares of Krystal Biotech in a note issued to investors on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn $2.55 per share for the quarter, up from […]
